APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Pharmaceuticals and Supplements

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Selected research

Market Analysis & Forecast

Global Equine Pharmaceuticals and Supplements Market Analysis and Forecast 2026-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchEquine Pharmaceuticals and Supplements Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Pharmaceuticals and Supplements Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Equine Pharmaceuticals and Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Pharmaceuticals and Supplements Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Pharmaceuticals and Supplements Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.

North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.

Read the full market overview

In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.

This report presents an overview of global market for Equine Pharmaceuticals and Supplements, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Equine Pharmaceuticals and Supplements, also provides the sales of main regions and countries. Of the upcoming market potential for Equine Pharmaceuticals and Supplements, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Equine Pharmaceuticals and Supplements sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Equine Pharmaceuticals and Supplements market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Equine Pharmaceuticals and Supplements sales, projected growth trends, production technology, application and end-user industry.

Equine Pharmaceuticals and Supplements Segment by Company

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

Equine Pharmaceuticals and Supplements Segment by Type

Pharmaceuticals

Supplements

Equine Pharmaceuticals and Supplements Segment by Application

Thoroughbred Horse

Other Types of Horses

Equine Pharmaceuticals and Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Pharmaceuticals and Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Pharmaceuticals and Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Pharmaceuticals and Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Equine Pharmaceuticals and Supplements in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Equine Pharmaceuticals and Supplements sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pharmaceuticals Major Manufacturers Table 3. Supplements Major Manufacturers Table 4. Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Thoroughbred Horse Major Manufacturers Table 6. Other Types of Horses Major Manufacturers Table 7. Equine Pharmaceuticals and Supplements Industry Trends Table 8. Equine Pharmaceuticals and Supplements Industry Drivers Table 9. Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges Table 10. Equine Pharmaceuticals and Supplements Industry Restraints Table 11. Global Equine Pharmaceuticals and Supplements Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Equine Pharmaceuticals and Supplements Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2021-2026) Table 15. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2027-2032) Table 16. Global Equine Pharmaceuticals and Supplements Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units) Table 18. Global Equine Pharmaceuticals and Supplements Sales by Region (2027-2032) & (K Units) Table 19. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2021-2026) Table 20. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2027-2032) Table 21. Global Equine Pharmaceuticals and Supplements Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2021-2026) Table 25. Global Equine Pharmaceuticals and Supplements Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 26. Global Equine Pharmaceuticals and Supplements Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Equine Pharmaceuticals and Supplements Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Equine Pharmaceuticals and Supplements Manufacturers, Product Type & Application Table 29. Global Equine Pharmaceuticals and Supplements Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Equine Pharmaceuticals and Supplements by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Equine Pharmaceuticals and Supplements Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Equine Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2026) Table 36. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2027-2032) Table 37. Global Equine Pharmaceuticals and Supplements Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 39. Global Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (K Units) Table 40. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021-2026) Table 41. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2027-2032) Table 42. Global Equine Pharmaceuticals and Supplements Price by Type (2021-2026) & (USD/Unit) Table 43. Global Equine Pharmaceuticals and Supplements Price by Type (2027-2032) & (USD/Unit) Table 44. Global Equine Pharmaceuticals and Supplements Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Equine Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2026) Table 48. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2027-2032) Table 49. Global Equine Pharmaceuticals and Supplements Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 51. Global Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (K Units) Table 52. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021-2026) Table 53. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2027-2032) Table 54. Global Equine Pharmaceuticals and Supplements Price by Application (2021-2026) & (USD/Unit) Table 55. Global Equine Pharmaceuticals and Supplements Price by Application (2027-2032) & (USD/Unit) Table 56. Boehringer Ingelheim Company Information Table 57. Boehringer Ingelheim Business Overview Table 58. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 59. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio Table 60. Boehringer Ingelheim Recent Development Table 61. Merck Animal Health Company Information Table 62. Merck Animal Health Business Overview Table 63. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 64. Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 65. Merck Animal Health Recent Development Table 66. Zoetis Company Information Table 67. Zoetis Business Overview Table 68. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Zoetis Equine Pharmaceuticals and Supplements Product Portfolio Table 70. Zoetis Recent Development Table 71. Bayer Animal Health Company Information Table 72. Bayer Animal Health Business Overview Table 73. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 75. Bayer Animal Health Recent Development Table 76. Elanco Animal Health Company Information Table 77. Elanco Animal Health Business Overview Table 78. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio Table 80. Elanco Animal Health Recent Development Table 81. Dechra Veterinary Products Company Information Table 82. Dechra Veterinary Products Business Overview Table 83. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio Table 85. Dechra Veterinary Products Recent Development Table 86. CEVA Company Information Table 87. CEVA Business Overview Table 88. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. CEVA Equine Pharmaceuticals and Supplements Product Portfolio Table 90. CEVA Recent Development Table 91. Virbac Company Information Table 92. Virbac Business Overview Table 93. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Virbac Equine Pharmaceuticals and Supplements Product Portfolio Table 95. Virbac Recent Development Table 96. Norbrook Equine Company Information Table 97. Norbrook Equine Business Overview Table 98. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio Table 100. Norbrook Equine Recent Development Table 101. Kyoritsu Seiyaku Company Information Table 102. Kyoritsu Seiyaku Business Overview Table 103. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio Table 105. Kyoritsu Seiyaku Recent Development Table 106. Vetoquinol Company Information Table 107. Vetoquinol Business Overview Table 108. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio Table 110. Vetoquinol Recent Development Table 111. Protexin Healthcare Company Information Table 112. Protexin Healthcare Business Overview Table 113. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio Table 115. Protexin Healthcare Recent Development Table 116. Audevard Company Information Table 117. Audevard Business Overview Table 118. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Audevard Equine Pharmaceuticals and Supplements Product Portfolio Table 120. Audevard Recent Development Table 121. Ouro Fino Saude Company Information Table 122. Ouro Fino Saude Business Overview Table 123. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio Table 125. Ouro Fino Saude Recent Development Table 126. North America Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Equine Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 129. North America Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (K Units) Table 130. North America Equine Pharmaceuticals and Supplements Sales Price by Type (2021-2026) & (USD/Unit) Table 131. North America Equine Pharmaceuticals and Supplements Sales Price by Type (2027-2032) & (USD/Unit) Table 132. North America Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Equine Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 135. North America Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (K Units) Table 136. North America Equine Pharmaceuticals and Supplements Sales Price by Application (2021-2026) & (USD/Unit) Table 137. North America Equine Pharmaceuticals and Supplements Sales Price by Application (2027-2032) & (USD/Unit) Table 138. North America Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. North America Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. North America Equine Pharmaceuticals and Supplements Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 143. North America Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 144. North America Equine Pharmaceuticals and Supplements Sales Price by Country (2021-2026) & (USD/Unit) Table 145. North America Equine Pharmaceuticals and Supplements Sales Price by Country (2027-2032) & (USD/Unit) Table 146. United States Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 147. Canada Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 148. Mexico Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 149. Europe Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Equine Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 152. Europe Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (K Units) Table 153. Europe Equine Pharmaceuticals and Supplements Sales Price by Type (2021-2026) & (USD/Unit) Table 154. Europe Equine Pharmaceuticals and Supplements Sales Price by Type (2027-2032) & (USD/Unit) Table 155. Europe Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (US$ Million) Table 156. Europe Equine Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (US$ Million) Table 157. Europe Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 158. Europe Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (K Units) Table 159. Europe Equine Pharmaceuticals and Supplements Sales Price by Application (2021-2026) & (USD/Unit) Table 160. Europe Equine Pharmaceuticals and Supplements Sales Price by Application (2027-2032) & (USD/Unit) Table 161. Europe Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Europe Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Europe Equine Pharmaceuticals and Supplements Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 165. Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 166. Europe Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 167. Europe Equine Pharmaceuticals and Supplements Sales Price by Country (2021-2026) & (USD/Unit) Table 168. Europe Equine Pharmaceuticals and Supplements Sales Price by Country (2027-2032) & (USD/Unit) Table 169. Germany Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 170. France Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 171. U.K. Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 172. Italy Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 173. Russia Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 174. Spain Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 175. Netherlands Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 176. Switzerland Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 177. Sweden Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 178. Poland Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 179. China Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (US$ Million) Table 180. China Equine Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (US$ Million) Table 181. China Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 182. China Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (K Units) Table 183. China Equine Pharmaceuticals and Supplements Sales Price by Type (2021-2026) & (USD/Unit) Table 184. China Equine Pharmaceuticals and Supplements Sales Price by Type (2027-2032) & (USD/Unit) Table 185. China Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (US$ Million) Table 186. China Equine Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (US$ Million) Table 187. China Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 188. China Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (K Units) Table 189. China Equine Pharmaceuticals and Supplements Sales Price by Application (2021-2026) & (USD/Unit) Table 190. China Equine Pharmaceuticals and Supplements Sales Price by Application (2027-2032) & (USD/Unit) Table 191. Asia Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (US$ Million) Table 192. Asia Equine Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (US$ Million) Table 193. Asia Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 194. Asia Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (K Units) Table 195. Asia Equine Pharmaceuticals and Supplements Sales Price by Type (2021-2026) & (USD/Unit) Table 196. Asia Equine Pharmaceuticals and Supplements Sales Price by Type (2027-2032) & (USD/Unit) Table 197. Asia Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (US$ Million) Table 198. Asia Equine Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (US$ Million) Table 199. Asia Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 200. Asia Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (K Units) Table 201. Asia Equine Pharmaceuticals and Supplements Sales Price by Application (2021-2026) & (USD/Unit) Table 202. Asia Equine Pharmaceuticals and Supplements Sales Price by Application (2027-2032) & (USD/Unit) Table 203. Asia Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Asia Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. Asia Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. Asia Equine Pharmaceuticals and Supplements Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 207. Asia Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 208. Asia Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 209. Asia Equine Pharmaceuticals and Supplements Sales Price by Country (2021-2026) & (USD/Unit) Table 210. Asia Equine Pharmaceuticals and Supplements Sales Price by Country (2027-2032) & (USD/Unit) Table 211. Japan Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 212. South Korea Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 213. India Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 214. Australia Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 215. Taiwan Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 216. Southeast Asia Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 217. SAMEA Equine Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (US$ Million) Table 218. SAMEA Equine Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (US$ Million) Table 219. SAMEA Equine Pharmaceuticals and Supplements Sales by Type (2021-2026) & (K Units) Table 220. SAMEA Equine Pharmaceuticals and Supplements Sales by Type (2027-2032) & (K Units) Table 221. SAMEA Equine Pharmaceuticals and Supplements Sales Price by Type (2021-2026) & (USD/Unit) Table 222. SAMEA Equine Pharmaceuticals and Supplements Sales Price by Type (2027-2032) & (USD/Unit) Table 223. SAMEA Equine Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (US$ Million) Table 224. SAMEA Equine Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (US$ Million) Table 225. SAMEA Equine Pharmaceuticals and Supplements Sales by Application (2021-2026) & (K Units) Table 226. SAMEA Equine Pharmaceuticals and Supplements Sales by Application (2027-2032) & (K Units) Table 227. SAMEA Equine Pharmaceuticals and Supplements Sales Price by Application (2021-2026) & (USD/Unit) Table 228. SAMEA Equine Pharmaceuticals and Supplements Sales Price by Application (2027-2032) & (USD/Unit) Table 229. SAMEA Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. SAMEA Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. SAMEA Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. SAMEA Equine Pharmaceuticals and Supplements Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 233. SAMEA Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units) Table 234. SAMEA Equine Pharmaceuticals and Supplements Sales by Country (2027-2032) & (K Units) Table 235. SAMEA Equine Pharmaceuticals and Supplements Sales Price by Country (2021-2026) & (USD/Unit) Table 236. SAMEA Equine Pharmaceuticals and Supplements Sales Price by Country (2027-2032) & (USD/Unit) Table 237. Brazil Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 238. Argentina Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 239. Chile Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 240. Colombia Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 241. Peru Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 242. Saudi Arabia Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 243. Israel Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 244. UAE Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 245. Turkey Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 246. Iran Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 247. Egypt Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Table 248. Key Raw Materials Table 249. Raw Materials Key Suppliers Table 250. Equine Pharmaceuticals and Supplements Distributors List Table 251. Equine Pharmaceuticals and Supplements Customers List Table 252. Research Programs/Design for This Report Table 253. Authors List of This Report Table 254. Secondary Sources Table 255. Primary Sources List of Figures Figure 1. Equine Pharmaceuticals and Supplements Image Figure 2. Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Pharmaceuticals and Supplements Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharmaceuticals Image Figure 5. Supplements Image Figure 6. Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Equine Pharmaceuticals and Supplements Market Size Share 2021 VS 2025 VS 2032 Figure 8. Thoroughbred Horse Image Figure 9. Other Types of Horses Image Figure 10. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Equine Pharmaceuticals and Supplements Revenue (2021-2032) & (US$ Million) Figure 12. Global Equine Pharmaceuticals and Supplements Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2021-2032) Figure 15. Global Equine Pharmaceuticals and Supplements Sales (2021-2032) & (K Units) Figure 16. Global Equine Pharmaceuticals and Supplements Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Equine Pharmaceuticals and Supplements Sales YoY (2021-2032) & (K Units) Figure 19. Europe Equine Pharmaceuticals and Supplements Sales YoY (2021-2032) & (K Units) Figure 20. China Equine Pharmaceuticals and Supplements Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Equine Pharmaceuticals and Supplements Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Equine Pharmaceuticals and Supplements Sales YoY (2021-2032) & (K Units) Figure 23. Global Equine Pharmaceuticals and Supplements Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Equine Pharmaceuticals and Supplements Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Equine Pharmaceuticals and Supplements Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032) Figure 29. Global Equine Pharmaceuticals and Supplements Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032) Figure 32. Global Equine Pharmaceuticals and Supplements Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032) Figure 35. Global Equine Pharmaceuticals and Supplements Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032) Figure 38. North America Equine Pharmaceuticals and Supplements Revenue Share by Type (2021-2032) Figure 39. North America Equine Pharmaceuticals and Supplements Sales Share by Type (2021-2032) Figure 40. North America Equine Pharmaceuticals and Supplements Revenue Share by Application (2021-2032) Figure 41. North America Equine Pharmaceuticals and Supplements Sales Share by Application (2021-2032) Figure 42. North America Equine Pharmaceuticals and Supplements Revenue Share by Country (2021-2032) Figure 43. North America Equine Pharmaceuticals and Supplements Sales Share by Country (2021-2032) Figure 44. Europe Equine Pharmaceuticals and Supplements Revenue Share by Type (2021-2032) Figure 45. Europe Equine Pharmaceuticals and Supplements Sales Share by Type (2021-2032) Figure 46. Europe Equine Pharmaceuticals and Supplements Revenue Share by Application (2021-2032) Figure 47. Europe Equine Pharmaceuticals and Supplements Sales Share by Application (2021-2032) Figure 48. Europe Equine Pharmaceuticals and Supplements Revenue Share by Country (2021-2032) Figure 49. Europe Equine Pharmaceuticals and Supplements Sales Share by Country (2021-2032) Figure 50. China Equine Pharmaceuticals and Supplements Revenue Share by Type (2021-2032) Figure 51. China Equine Pharmaceuticals and Supplements Sales Share by Type (2021-2032) Figure 52. China Equine Pharmaceuticals and Supplements Revenue Share by Application (2021-2032) Figure 53. China Equine Pharmaceuticals and Supplements Sales Share by Application (2021-2032) Figure 54. Asia Equine Pharmaceuticals and Supplements Revenue Share by Type (2021-2032) Figure 55. Asia Equine Pharmaceuticals and Supplements Sales Share by Type (2021-2032) Figure 56. Asia Equine Pharmaceuticals and Supplements Revenue Share by Application (2021-2032) Figure 57. Asia Equine Pharmaceuticals and Supplements Sales Share by Application (2021-2032) Figure 58. Asia Equine Pharmaceuticals and Supplements Revenue Share by Country (2021-2032) Figure 59. Asia Equine Pharmaceuticals and Supplements Sales Share by Country (2021-2032) Figure 60. SAMEA Equine Pharmaceuticals and Supplements Revenue Share by Type (2021-2032) Figure 61. SAMEA Equine Pharmaceuticals and Supplements Sales Share by Type (2021-2032) Figure 62. SAMEA Equine Pharmaceuticals and Supplements Revenue Share by Application (2021-2032) Figure 63. SAMEA Equine Pharmaceuticals and Supplements Sales Share by Application (2021-2032) Figure 64. SAMEA Equine Pharmaceuticals and Supplements Revenue Share by Country (2021-2032) Figure 65. SAMEA Equine Pharmaceuticals and Supplements Sales Share by Country (2021-2032) Figure 66. Equine Pharmaceuticals and Supplements Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Equine Pharmaceuticals and Supplements Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceuticals
  • Supplements
Applications
  • Thoroughbred Horse
  • Other Types of Horses
Companies covered
  • Boehringer Ingelheim
  • Merck Animal Health
  • Zoetis
  • Bayer Animal Health
  • Elanco Animal Health
  • Dechra Veterinary Products
  • CEVA
  • Virbac
  • Norbrook Equine
  • Kyoritsu Seiyaku
  • Vetoquinol
  • Protexin Healthcare
  • Audevard
  • Ouro Fino Saude

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Equine Pharmaceuticals and Supplements Market by Type
  3. 1.2.1 Global Equine Pharmaceuticals and Supplements Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pharmaceuticals
  5. 1.2.3 Supplements
  6. 1.3 Equine Pharmaceuticals and Supplements Market by Application
  7. 1.3.1 Global Equine Pharmaceuticals and Supplements Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Thoroughbred Horse
  9. 1.3.3 Other Types of Horses
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Equine Pharmaceuticals and Supplements Market Dynamics
  1. 2.1 Equine Pharmaceuticals and Supplements Industry Trends
  2. 2.2 Equine Pharmaceuticals and Supplements Industry Drivers
  3. 2.3 Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges
  4. 2.4 Equine Pharmaceuticals and Supplements Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Equine Pharmaceuticals and Supplements Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Equine Pharmaceuticals and Supplements Revenue by Region
  3. 3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026)
  5. 3.2.3 Global Equine Pharmaceuticals and Supplements Revenue by Region (2027-2032)
  6. 3.2.4 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Equine Pharmaceuticals and Supplements Sales by Region
  9. 3.4.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Equine Pharmaceuticals and Supplements Sales by Region (2021-2026)
  11. 3.4.3 Global Equine Pharmaceuticals and Supplements Sales by Region (2027-2032)
  12. 3.4.4 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturers
  2. 4.1.1 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Equine Pharmaceuticals and Supplements Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers
  6. 4.2.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Equine Pharmaceuticals and Supplements Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Equine Pharmaceuticals and Supplements Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Equine Pharmaceuticals and Supplements Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Equine Pharmaceuticals and Supplements Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Equine Pharmaceuticals and Supplements Manufacturers, Product Type & Application
  13. 4.7 Global Equine Pharmaceuticals and Supplements Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Equine Pharmaceuticals and Supplements Market CR5 and HHI
  16. 4.8.2 2025 Equine Pharmaceuticals and Supplements Tier 1, Tier 2, and Tier 3
5 Equine Pharmaceuticals and Supplements Market by Type
  1. 5.1 Global Equine Pharmaceuticals and Supplements Revenue by Type
  2. 5.1.1 Global Equine Pharmaceuticals and Supplements Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Equine Pharmaceuticals and Supplements Sales by Type
  6. 5.2.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Equine Pharmaceuticals and Supplements Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032)
  9. 5.3 Global Equine Pharmaceuticals and Supplements Price by Type
6 Equine Pharmaceuticals and Supplements Market by Application
  1. 6.1 Global Equine Pharmaceuticals and Supplements Revenue by Application
  2. 6.1.1 Global Equine Pharmaceuticals and Supplements Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Equine Pharmaceuticals and Supplements Sales by Application
  6. 6.2.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Equine Pharmaceuticals and Supplements Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032)
  9. 6.3 Global Equine Pharmaceuticals and Supplements Price by Application
7 Company Profiles
  1. 7.1 Boehringer Ingelheim
  2. 7.1.1 Boehringer Ingelheim Company Information
  3. 7.1.2 Boehringer Ingelheim Business Overview
  4. 7.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
  6. 7.1.5 Boehringer Ingelheim Recent Developments
  7. 7.2 Merck Animal Health
  8. 7.2.1 Merck Animal Health Company Information
  9. 7.2.2 Merck Animal Health Business Overview
  10. 7.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  12. 7.2.5 Merck Animal Health Recent Developments
  13. 7.3 Zoetis
  14. 7.3.1 Zoetis Company Information
  15. 7.3.2 Zoetis Business Overview
  16. 7.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
  18. 7.3.5 Zoetis Recent Developments
  19. 7.4 Bayer Animal Health
  20. 7.4.1 Bayer Animal Health Company Information
  21. 7.4.2 Bayer Animal Health Business Overview
  22. 7.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  24. 7.4.5 Bayer Animal Health Recent Developments
  25. 7.5 Elanco Animal Health
  26. 7.5.1 Elanco Animal Health Company Information
  27. 7.5.2 Elanco Animal Health Business Overview
  28. 7.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
  30. 7.5.5 Elanco Animal Health Recent Developments
  31. 7.6 Dechra Veterinary Products
  32. 7.6.1 Dechra Veterinary Products Company Information
  33. 7.6.2 Dechra Veterinary Products Business Overview
  34. 7.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
  36. 7.6.5 Dechra Veterinary Products Recent Developments
  37. 7.7 CEVA
  38. 7.7.1 CEVA Company Information
  39. 7.7.2 CEVA Business Overview
  40. 7.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
  42. 7.7.5 CEVA Recent Developments
  43. 7.8 Virbac
  44. 7.8.1 Virbac Company Information
  45. 7.8.2 Virbac Business Overview
  46. 7.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
  48. 7.8.5 Virbac Recent Developments
  49. 7.9 Norbrook Equine
  50. 7.9.1 Norbrook Equine Company Information
  51. 7.9.2 Norbrook Equine Business Overview
  52. 7.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
  54. 7.9.5 Norbrook Equine Recent Developments
  55. 7.10 Kyoritsu Seiyaku
  56. 7.10.1 Kyoritsu Seiyaku Company Information
  57. 7.10.2 Kyoritsu Seiyaku Business Overview
  58. 7.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
  60. 7.10.5 Kyoritsu Seiyaku Recent Developments
  61. 7.11 Vetoquinol
  62. 7.11.1 Vetoquinol Company Information
  63. 7.11.2 Vetoquinol Business Overview
  64. 7.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
  66. 7.11.5 Vetoquinol Recent Developments
  67. 7.12 Protexin Healthcare
  68. 7.12.1 Protexin Healthcare Company Information
  69. 7.12.2 Protexin Healthcare Business Overview
  70. 7.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
  72. 7.12.5 Protexin Healthcare Recent Developments
  73. 7.13 Audevard
  74. 7.13.1 Audevard Company Information
  75. 7.13.2 Audevard Business Overview
  76. 7.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
  78. 7.13.5 Audevard Recent Developments
  79. 7.14 Ouro Fino Saude
  80. 7.14.1 Ouro Fino Saude Company Information
  81. 7.14.2 Ouro Fino Saude Business Overview
  82. 7.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
  84. 7.14.5 Ouro Fino Saude Recent Developments
8 North America
  1. 8.1 North America Equine Pharmaceuticals and Supplements Market Size by Type
  2. 8.1.1 North America Equine Pharmaceuticals and Supplements Revenue by Type (2021-2032)
  3. 8.1.2 North America Equine Pharmaceuticals and Supplements Sales by Type (2021-2032)
  4. 8.1.3 North America Equine Pharmaceuticals and Supplements Price by Type (2021-2032)
  5. 8.2 North America Equine Pharmaceuticals and Supplements Market Size by Application
  6. 8.2.1 North America Equine Pharmaceuticals and Supplements Revenue by Application (2021-2032)
  7. 8.2.2 North America Equine Pharmaceuticals and Supplements Sales by Application (2021-2032)
  8. 8.2.3 North America Equine Pharmaceuticals and Supplements Price by Application (2021-2032)
  9. 8.3 North America Equine Pharmaceuticals and Supplements Market Size by Country
  10. 8.3.1 North America Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Equine Pharmaceuticals and Supplements Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Equine Pharmaceuticals and Supplements Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Equine Pharmaceuticals and Supplements Market Size by Type
  2. 9.1.1 Europe Equine Pharmaceuticals and Supplements Revenue by Type (2021-2032)
  3. 9.1.2 Europe Equine Pharmaceuticals and Supplements Sales by Type (2021-2032)
  4. 9.1.3 Europe Equine Pharmaceuticals and Supplements Price by Type (2021-2032)
  5. 9.2 Europe Equine Pharmaceuticals and Supplements Market Size by Application
  6. 9.2.1 Europe Equine Pharmaceuticals and Supplements Revenue by Application (2021-2032)
  7. 9.2.2 Europe Equine Pharmaceuticals and Supplements Sales by Application (2021-2032)
  8. 9.2.3 Europe Equine Pharmaceuticals and Supplements Price by Application (2021-2032)
  9. 9.3 Europe Equine Pharmaceuticals and Supplements Market Size by Country
  10. 9.3.1 Europe Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Equine Pharmaceuticals and Supplements Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Equine Pharmaceuticals and Supplements Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Equine Pharmaceuticals and Supplements Market Size by Type
  2. 10.1.1 China Equine Pharmaceuticals and Supplements Revenue by Type (2021-2032)
  3. 10.1.2 China Equine Pharmaceuticals and Supplements Sales by Type (2021-2032)
  4. 10.1.3 China Equine Pharmaceuticals and Supplements Price by Type (2021-2032)
  5. 10.2 China Equine Pharmaceuticals and Supplements Market Size by Application
  6. 10.2.1 China Equine Pharmaceuticals and Supplements Revenue by Application (2021-2032)
  7. 10.2.2 China Equine Pharmaceuticals and Supplements Sales by Application (2021-2032)
  8. 10.2.3 China Equine Pharmaceuticals and Supplements Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Equine Pharmaceuticals and Supplements Market Size by Type
  2. 11.1.1 Asia Equine Pharmaceuticals and Supplements Revenue by Type (2021-2032)
  3. 11.1.2 Asia Equine Pharmaceuticals and Supplements Sales by Type (2021-2032)
  4. 11.1.3 Asia Equine Pharmaceuticals and Supplements Price by Type (2021-2032)
  5. 11.2 Asia Equine Pharmaceuticals and Supplements Market Size by Application
  6. 11.2.1 Asia Equine Pharmaceuticals and Supplements Revenue by Application (2021-2032)
  7. 11.2.2 Asia Equine Pharmaceuticals and Supplements Sales by Application (2021-2032)
  8. 11.2.3 Asia Equine Pharmaceuticals and Supplements Price by Application (2021-2032)
  9. 11.3 Asia Equine Pharmaceuticals and Supplements Market Size by Country
  10. 11.3.1 Asia Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Equine Pharmaceuticals and Supplements Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Equine Pharmaceuticals and Supplements Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Equine Pharmaceuticals and Supplements Market Size by Type
  2. 12.1.1 SAMEA Equine Pharmaceuticals and Supplements Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Equine Pharmaceuticals and Supplements Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Equine Pharmaceuticals and Supplements Price by Type (2021-2032)
  5. 12.2 SAMEA Equine Pharmaceuticals and Supplements Market Size by Application
  6. 12.2.1 SAMEA Equine Pharmaceuticals and Supplements Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Equine Pharmaceuticals and Supplements Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Equine Pharmaceuticals and Supplements Price by Application (2021-2032)
  9. 12.3 SAMEA Equine Pharmaceuticals and Supplements Market Size by Country
  10. 12.3.1 SAMEA Equine Pharmaceuticals and Supplements Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Equine Pharmaceuticals and Supplements Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Equine Pharmaceuticals and Supplements Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Equine Pharmaceuticals and Supplements Value Chain Analysis
  2. 13.1.1 Equine Pharmaceuticals and Supplements Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Equine Pharmaceuticals and Supplements Production Mode & Process
  6. 13.2 Equine Pharmaceuticals and Supplements Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Equine Pharmaceuticals and Supplements Distributors
  9. 13.2.3 Equine Pharmaceuticals and Supplements Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst